Elucidation of the 1-phenethylisoquinoline pathway from an endemic conifer <i>Cephalotaxus hainanensis</i>.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36577068.
- Also identified by DOI 10.1073/pnas.2209339120 and PMC identifier 9910586.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cephalotaxines harbor great medical potential, but their natural source, the endemic conifer <i>Cephalotaxus</i> is highly endangered, creating a conflict between biotechnological valorization and preservation of biodiversity. Here, we construct the whole biosynthetic pathway to the 1-phenethylisoquinoline scaffold, as first committed compound for phenylethylisoquinoline alkaloids (PIAs), combining metabolic modeling, and transcriptome mining of <i>Cephalotaxus hainanensis</i> to infer the biosynthesis for PIA precursor. We identify a novel protein, <i>Ch</i>PSS, driving the Pictet-Spengler condensation and show that this enzyme represents the branching point where PIA biosynthesis diverges from the concurrent benzylisoquinoline-alkaloids pathway. We also pinpoint <i>Ch</i>DBR as crucial step to form 4-hydroxydihydrocinnamaldehyde diverging from lignin biosynthesis. The elucidation of the early PIA pathway represents an important step toward microbe-based production of these pharmaceutically important alkaloids resolving the conflict between biotechnology and preservation of biodiversity.
Medical subject headings
- Cephalotaxus
- Alkaloids
- Benzylisoquinolines